Safety study of injectable SPN01 for healthy people and colorectal cancer patients
Part of Cancer, Digestive system clinical trials.
This trial tests an investigational drug called SPN01 to see if it is safe and how the body processes it. It includes both healthy volunteers and people with colorectal cancer who are scheduled for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–45 for healthy volunteers, or 18–75 for colorectal cancer patients.
- Body mass index (BMI) between 19 and 26, and minimum weight of 50 kg for men, 45 kg for women.
- Healthy volunteers must have normal kidney function and lab results.
- Colorectal cancer patients must have a confirmed diagnosis, be scheduled for surgery, and have had no prior targeted cancer treatments.
- Must use effective birth control during the study and for 30 days after the dose.
- No serious medical conditions, active infections, or recent participation in other drug trials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new mRNA medicine called SPOT-mRNA01 given as a shot under the skin. It aims to see if it is safe and tolerable in healthy volunteers.
This trial tests a new drug called SPX-303, which is designed to help your immune system fight cancer cells. It is for people with advanced solid tumors that have not responded to other treatments.
This early-stage trial tests a new radioactive medicine called SNA028 for patients with advanced colorectal cancer that has returned or grown despite prior treatment. The medicine is designed to target cancer cells that have a specific marker called GPA33.
This early-phase trial tests a new drug called SPH7854 granules in healthy people to check how the body processes it and if it's safe. You would take the drug and have regular check-ups.
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
This trial tests a new medicine called SP-101 given by IV infusion. It is the first time SP-101 is given to humans, and the study will check how safe it is and how the body handles it. It may help researchers decide the right dose for future studies.
Hear when a new Colorectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.